Qingdao Vland Biotech INC Stock

Qingdao Vland Biotech INC Revenue 2024

Qingdao Vland Biotech INC Revenue

1.32 B CNY

Ticker

603739.SS

ISIN

CNE100003GX8

In 2024, Qingdao Vland Biotech INC's sales reached 1.32 B CNY, a 10.1% difference from the 1.2 B CNY sales recorded in the previous year.

The Qingdao Vland Biotech INC Revenue history

YEARREVENUE (undefined CNY)GROSS MARGIN (%)
2026e1.6234,06
2025e1.4737,55
2024e1.3241,70
20231.245,91
20221.1643,01
20211.1546,09
20200.9648,32
20190.8548,29
20180.8149,68
20170.851,94
20160.7854,49
20150.7551,95

Qingdao Vland Biotech INC Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

Understanding Revenue, EBIT, and Income

Gain insights into Qingdao Vland Biotech INC, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Qingdao Vland Biotech INC from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Qingdao Vland Biotech INC’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Qingdao Vland Biotech INC. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Qingdao Vland Biotech INC’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Qingdao Vland Biotech INC’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Qingdao Vland Biotech INC’s growth potential.

Qingdao Vland Biotech INC Revenue, EBIT and net profit per share

DateQingdao Vland Biotech INC RevenueQingdao Vland Biotech INC EBITQingdao Vland Biotech INC Net Income
2026e1.62 B undefined186.08 M undefined143.96 M undefined
2025e1.47 B undefined0 undefined124.37 M undefined
2024e1.32 B undefined0 undefined109.89 M undefined
20231.2 B undefined124.81 M undefined80.71 M undefined
20221.16 B undefined103.96 M undefined69.84 M undefined
20211.15 B undefined167.3 M undefined132.57 M undefined
2020960.2 M undefined141.4 M undefined109 M undefined
2019846.8 M undefined91.7 M undefined77.8 M undefined
2018814 M undefined111.9 M undefined83.4 M undefined
2017799.4 M undefined119.1 M undefined85.6 M undefined
2016781.2 M undefined100.6 M undefined82.6 M undefined
2015751.7 M undefined70.2 M undefined70.3 M undefined

Qingdao Vland Biotech INC stock margins

The Qingdao Vland Biotech INC margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Qingdao Vland Biotech INC. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Qingdao Vland Biotech INC.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Qingdao Vland Biotech INC's sales revenue. A higher gross margin percentage indicates that the Qingdao Vland Biotech INC retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Qingdao Vland Biotech INC's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Qingdao Vland Biotech INC's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Qingdao Vland Biotech INC's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Qingdao Vland Biotech INC. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Qingdao Vland Biotech INC's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Qingdao Vland Biotech INC Margin History

Qingdao Vland Biotech INC Gross marginQingdao Vland Biotech INC Profit marginQingdao Vland Biotech INC EBIT marginQingdao Vland Biotech INC Profit margin
2026e45.91 %11.51 %8.91 %
2025e45.91 %0 %8.48 %
2024e45.91 %0 %8.33 %
202345.91 %10.41 %6.73 %
202243.01 %8.94 %6 %
202146.09 %14.54 %11.52 %
202048.32 %14.73 %11.35 %
201948.29 %10.83 %9.19 %
201849.68 %13.75 %10.25 %
201751.94 %14.9 %10.71 %
201654.49 %12.88 %10.57 %
201551.95 %9.34 %9.35 %

Qingdao Vland Biotech INC Aktienanalyse

What does Qingdao Vland Biotech INC do?

Qingdao Vland Biotech INC ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Revenue Details

Understanding Qingdao Vland Biotech INC's Sales Figures

The sales figures of Qingdao Vland Biotech INC originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing Qingdao Vland Biotech INC’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize Qingdao Vland Biotech INC's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in Qingdao Vland Biotech INC’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about Qingdao Vland Biotech INC stock

How much revenue did Qingdao Vland Biotech INC generate this year?

Qingdao Vland Biotech INC has achieved a revenue of 1.32 B CNY this year.

How much was the turnover of the company Qingdao Vland Biotech INC compared to the previous year?

The revenue of Qingdao Vland Biotech INC has increased by 10.1% increased compared to the previous year.

What does revenue mean for investors?

The revenue of a company is an important indicator of its financial performance and attractiveness for investors.

Which factors influence the revenue of Qingdao Vland Biotech INC?

The revenue of Qingdao Vland Biotech INC is influenced by various factors, including the demand for its products and services, market conditions, and prices.

How is the revenue of Qingdao Vland Biotech INC measured?

Revenue is typically measured in units referring to the sale of goods and services provided by the company.

How does an increase in sales affect investments?

An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.

What are the possible risks associated with a declining revenue?

A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.

Why is the sales revenue of Qingdao Vland Biotech INC so important for investors?

The revenue of Qingdao Vland Biotech INC is an important indicator of financial performance and attractiveness for investors.

What strategic measures can a company take to increase revenue?

A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.

How much dividend does Qingdao Vland Biotech INC pay?

Over the past 12 months, Qingdao Vland Biotech INC paid a dividend of 0.1 CNY . This corresponds to a dividend yield of about 0.85 %. For the coming 12 months, Qingdao Vland Biotech INC is expected to pay a dividend of 0.1 CNY.

What is the dividend yield of Qingdao Vland Biotech INC?

The current dividend yield of Qingdao Vland Biotech INC is 0.85 %.

When does Qingdao Vland Biotech INC pay dividends?

Qingdao Vland Biotech INC pays a quarterly dividend. This is distributed in the months of June, June, June, June.

How secure is the dividend of Qingdao Vland Biotech INC?

Qingdao Vland Biotech INC paid dividends every year for the past 8 years.

What is the dividend of Qingdao Vland Biotech INC?

For the upcoming 12 months, dividends amounting to 0.1 CNY are expected. This corresponds to a dividend yield of 0.87 %.

In which sector is Qingdao Vland Biotech INC located?

Qingdao Vland Biotech INC is assigned to the 'Health' sector.

Wann musste ich die Aktien von Qingdao Vland Biotech INC kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Qingdao Vland Biotech INC from 5/30/2024 amounting to 0.1 CNY, you needed to have the stock in your portfolio before the ex-date on 5/30/2024.

When did Qingdao Vland Biotech INC pay the last dividend?

The last dividend was paid out on 5/30/2024.

What was the dividend of Qingdao Vland Biotech INC in the year 2023?

In the year 2023, Qingdao Vland Biotech INC distributed 0.16 CNY as dividends.

In which currency does Qingdao Vland Biotech INC pay out the dividend?

The dividends of Qingdao Vland Biotech INC are distributed in CNY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Qingdao Vland Biotech INC

Our stock analysis for Qingdao Vland Biotech INC Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Qingdao Vland Biotech INC Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.